24 May 2013
Keywords: gilead, share, price, up, strong, 4th-qtr, sales
Article | 12 February 2007
US drugmaker Gilead Sciences says that, for the fourth quarter of 2006, it recorded a loss of $1.67 billion, or $3.63 per share. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.